IL36671A - 1-alkoxyalkyl(cycloalkylalkyl)-5-(o-alkylphenyl)-7-halo-1,3-dihydro-2h-1,4-benzodiazepin-2-ones,processes for their preparation and pharmaceutical compositions containing the same - Google Patents
1-alkoxyalkyl(cycloalkylalkyl)-5-(o-alkylphenyl)-7-halo-1,3-dihydro-2h-1,4-benzodiazepin-2-ones,processes for their preparation and pharmaceutical compositions containing the sameInfo
- Publication number
- IL36671A IL36671A IL36671A IL3667171A IL36671A IL 36671 A IL36671 A IL 36671A IL 36671 A IL36671 A IL 36671A IL 3667171 A IL3667171 A IL 3667171A IL 36671 A IL36671 A IL 36671A
- Authority
- IL
- Israel
- Prior art keywords
- benzodiazepin
- cycloalkylalkyl
- alkylphenyl
- alkoxyalkyl
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/28—Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
- C07D243/30—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings
- C07D243/32—Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings containing a phthalimide or hydrogenated phthalimide ring system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Package Closures (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP45035735A JPS494226B1 (fr) | 1970-04-23 | 1970-04-23 | |
JP4149870A JPS499474B1 (fr) | 1970-05-14 | 1970-05-14 | |
JP4149970A JPS4911238B1 (fr) | 1970-05-14 | 1970-05-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL36671A0 IL36671A0 (en) | 1971-06-23 |
IL36671A true IL36671A (en) | 1975-02-10 |
Family
ID=27288853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL36671A IL36671A (en) | 1970-04-23 | 1971-04-21 | 1-alkoxyalkyl(cycloalkylalkyl)-5-(o-alkylphenyl)-7-halo-1,3-dihydro-2h-1,4-benzodiazepin-2-ones,processes for their preparation and pharmaceutical compositions containing the same |
Country Status (7)
Country | Link |
---|---|
BE (1) | BE766098A (fr) |
DE (1) | DE2166444A1 (fr) |
FR (1) | FR2092074B1 (fr) |
GB (1) | GB1307144A (fr) |
IL (1) | IL36671A (fr) |
NL (1) | NL7105495A (fr) |
NO (1) | NO132869C (fr) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL138936B (nl) * | 1967-12-06 | 1973-05-15 | Sumitomo Chemical Co | Werkwijze voor het bereiden van benzodiazepinederivaten, alsmede hieruit bereid farmaceutisch preparaat. |
US3778433A (en) * | 1969-04-18 | 1973-12-11 | Sumitomo Chemical Co | Process for producing benzodiazepine derivatives |
-
1971
- 1971-04-19 GB GB2706471*A patent/GB1307144A/en not_active Expired
- 1971-04-20 NO NO1462/71A patent/NO132869C/no unknown
- 1971-04-21 FR FR7114156A patent/FR2092074B1/fr not_active Expired
- 1971-04-21 IL IL36671A patent/IL36671A/xx unknown
- 1971-04-22 DE DE19712166444 patent/DE2166444A1/de active Pending
- 1971-04-22 BE BE766098A patent/BE766098A/fr unknown
- 1971-04-22 NL NL7105495A patent/NL7105495A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NO132869B (fr) | 1975-10-13 |
GB1307144A (en) | 1973-02-14 |
NL7105495A (fr) | 1971-10-26 |
FR2092074B1 (fr) | 1974-10-18 |
NO132869C (fr) | 1976-01-21 |
BE766098A (fr) | 1971-09-16 |
FR2092074A1 (fr) | 1972-01-21 |
IL36671A0 (en) | 1971-06-23 |
DE2166444A1 (de) | 1974-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL38364A (en) | 8-azapurin-6-one derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL36299A0 (en) | 3-octadecyloxypropyl-2'-trimethylammoniumethyl phosphate,its preparation and pharmaceutical compositions containing it | |
PH9682A (en) | 1,2,3,4-tetrahydro-4-phenyl-isoquinoline derivatives and pharmaceutical composition containing same | |
IL30282A (en) | 1,4-benzodiazepines and benzodiazepin-2-ones,their preparation and pharmaceutical compositions containing them | |
IL37598A0 (en) | Bis-chromonyloxy compounds,their preparation and pharmaceutical compositions containing them | |
PH10182A (en) | 1-substituted-1,3-dihydro-2h-1,4-benzodiazepine-2-ones and its pharmaceutical composition | |
IL36743A (en) | Phenylaminoalkanes,their preparation and pharmaceutical compositions containing them | |
IL36671A (en) | 1-alkoxyalkyl(cycloalkylalkyl)-5-(o-alkylphenyl)-7-halo-1,3-dihydro-2h-1,4-benzodiazepin-2-ones,processes for their preparation and pharmaceutical compositions containing the same | |
IL37588A0 (en) | Pyrimidoisoquinolines,their preparation and pharmaceutical compositions containing them | |
IL36285A0 (en) | Erythromycylamine compounds,processes for preparation thereof and pharmaceutical compositions containing them | |
IL37230A0 (en) | Benzodiazepine derivatives,their manufacture and pharmaceutical compositions containing them | |
IL37047A0 (en) | Substituted amidines,their preparation and pharmaceutical compositions containing them | |
IL36127A (en) | 6alpha,9alpha-difluoro-11beta,21-dihydroxy-16alpha,17alpha-isopropylidenedioxy-pregna-1,4diene 21-esters,their preparation and pharmaceutical compositions containing them | |
IL36549A (en) | Substituted imidazolines-(2),their preparation and pharmaceutical compositions containing them | |
IL36160A0 (en) | Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them | |
PH10045A (en) | 1-substituted-5-(0-alkylphenyl-7-halogeno-1,3-dihydro-2h-1,4-benzodiazepin-2-one and pharmaceutical compositions | |
IL37609A (en) | Ethers of 1-hydroxyalkyl-5-phenyl-1,3-dihydro-2h-1,4 benzodiazepin-2-ones,processes for their preparation and pharmaceutical compositions containing the same | |
IL36397A (en) | N-vinyl-quinolones,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL35976A0 (en) | Cardenolide-rhamnosides,their preparation and pharmaceutical compositions containing them | |
IL34689A0 (en) | 1h-2,3,4,5-tetrahydro-1,5-benzodiazepin-4-ones,their preparation and pharmaceutical compositions containing them | |
IL33119A (en) | 4,5-epoxy-1,3,4,5-tetrahydro-5-phenyl-2h-1,4-benzodiazepin-2-one derivatives,their preparation and pharmaceutical compositions containing them | |
IL36056A0 (en) | Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them | |
IL38234A0 (en) | Benzodiazepine derivatives,their manufacture and pharmaceutical compositions containing them | |
IL37644A0 (en) | Benzodiazepine derivatives,their manufacture and pharmaceutical compositions containing them | |
IL34760A0 (en) | 1,4-benzodiazepin-2-one derivatives,their preparation and pharmaceutical compositions containing them |